• News
  • Stock Screener
  • Small Caps
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Review
  • X (Twitter)

Stock Screener

Show:

Sort

Country

Sector

Risk rating

1
2
3
4
5
6
7

Risk factors

    Default risk

    1
    2
    3
    4
    5
    6
    7

    Volatility

    1
    2
    3
    4
    5
    6
    7

    Stress test

    1
    2
    3
    4
    5
    6
    7

    Selling difficulty

    1
    2
    3
    4
    5
    6
    7

    Country risks

    1
    2
    3
    4
    5
    6
    7

    Other risks

    1
    2
    3
    4
    5
    6
    7

Profitability factors

    Valuation

    1
    2
    3
    4
    5
    6
    7

    Analyst view

    1
    2
    3
    4
    5
    6
    7

    Performance

    1
    2
    3
    4
    5
    6
    7

    Profitability

    1
    2
    3
    4
    5
    6
    7

    Growth

    1
    2
    3
    4
    5
    6
    7

    Dividends

    1
    2
    3
    4
    5
    6
    7

    Results: 131

    ALTEOGEN Inc.

    196170.KQ
    3

    ABL Bio Inc.

    298380.KQ
    4

    OliX Pharmaceuticals, Inc

    226950.KQ
    2

    D&D Pharmatech

    347850.KQ
    2

    PharmaResearch Co., Ltd.

    214450.KQ
    4

    Samsung Biologics Co.,Ltd.

    207940.KS
    5

    Peptron, Inc.

    087010.KQ
    1

    LigaChem Biosciences Inc.

    141080.KQ
    3

    Celltrion, Inc.

    068270.KS
    5

    Sam Chun Dang Pharm. Co., Ltd

    000250.KQ
    3

    Ildong Pharmaceutical Co., Ltd.

    249420.KS
    2

    Yuhan Corporation

    000100.KS
    4

    L&C BIO Co.,LTD

    290650.KQ
    4

    Onconic Therapeutics

    476060.KQ
    2

    Xiangyu Medical Co.,Ltd

    688626.SS
    4

    HLB Co., Ltd.

    028300.KQ
    1

    SK Biopharmaceuticals Co., Ltd.

    326030.KS
    4

    Hanmi Pharm. Co., Ltd.

    128940.KS
    4

    Pharmicell Co., Ltd.

    005690.KS
    2

    ST Pharm Co.,Ltd.

    237690.KQ
    4
X-channel

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • X (Twitter)
Oninvest© 2025